A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT02501161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT02501161
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 1,012 participants
Conditions and interventions
Conditions
Interventions
- insulin degludec/liraglutide Drug
- insulin glargine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2016
- Primary completion
- Oct 2, 2018
- Completion
- Oct 2, 2018
- Last update posted
- Nov 26, 2019
2016 – 2018
United States locations
- U.S. sites
- 44
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Muscle Shoals | Alabama | 35662 | — |
| Novo Nordisk Investigational Site | Tuscumbia | Alabama | 35674 | — |
| Novo Nordisk Investigational Site | Glendale | Arizona | 85306-4652 | — |
| Novo Nordisk Investigational Site | Glendale | Arizona | 85308 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85018 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85020 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85050 | — |
| Novo Nordisk Investigational Site | Bermuda Dunes | California | 92203 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Lancaster | California | 93534 | — |
| Novo Nordisk Investigational Site | Monterey | California | 93940 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95821 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Ventura | California | 93003 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80910 | — |
| Novo Nordisk Investigational Site | Boynton Beach | Florida | 33472 | — |
| Novo Nordisk Investigational Site | Lake Worth | Florida | 33461 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33135 | — |
| Novo Nordisk Investigational Site | Blackfoot | Idaho | 83221 | — |
| Novo Nordisk Investigational Site | Avon | Indiana | 46123 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46254 | — |
| Novo Nordisk Investigational Site | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Waltham | Massachusetts | 02453 | — |
| Novo Nordisk Investigational Site | Buckley | Michigan | 49620 | — |
| Novo Nordisk Investigational Site | Billings | Montana | 59101 | — |
| Novo Nordisk Investigational Site | Nashua | New Hampshire | 03063 | — |
| Novo Nordisk Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Novo Nordisk Investigational Site | New Windsor | New York | 12553 | — |
| Novo Nordisk Investigational Site | Mason | Ohio | 45040-6815 | — |
| Novo Nordisk Investigational Site | Maumee | Ohio | 43537 | — |
| Novo Nordisk Investigational Site | Beaver | Pennsylvania | 15009 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Humboldt | Tennessee | 38343 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75251 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77040 | — |
| Novo Nordisk Investigational Site | Irving | Texas | 75061-2210 | — |
| Novo Nordisk Investigational Site | Katy | Texas | 77450 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78215 | — |
| Novo Nordisk Investigational Site | Midlothian | Virginia | 23114 | — |
| Novo Nordisk Investigational Site | Kenosha | Wisconsin | 53142 | — |
| Novo Nordisk Investigational Site | Kenosha | Wisconsin | 53144 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02501161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2019 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02501161 live on ClinicalTrials.gov.